Assistant Professor, Department of Population Health
I am an ethicist, a public health professional, and a medical historian. My research is primarily focused on ethics and policy issues concerning access to investigational medical products, both inside and outside of clinical trials. One particular area of interest is in the equity of access: who gets access to what, how?
In recent years, my colleagues and I have become interested in several areas of active inquiry: 1) can useful efficacy data be obtained from non-trial uses of unapproved medical products; 2) how to most ethically and pragmatically advance the new field of individualized therapeutics; 3) the ethics of pediatric gene therapy trials; and 4) what amount of and quality of data is needed to make clinical & regulatory decisions.
I am also interested in and conducted research on the history, ethics, & public policy of mandatory helmet laws.
PhD from Columbia University
MPH from Columbia University
NYU Grossman School of Medicine, Division of Medical Ethics
Annals of internal medicine. 2015 Nov 17; 163(10):796-7
Expert opinion on pharmacotherapy. 2015 Jun; 16(9):1275-9
Nucleic acid therapeutics. 2021 Nov 19;
American journal of bioethics : AJOB. 2021 Oct 19; 1-16
Molecular therapy. 2021 Apr 07; 29(4):1367-1369
Science. 2020 Dec 18; 370(6523):1423-1424
American journal of public health. AJPH. 2020 Aug; 110(8):1198-1204